Caricamento...
Nintedanib prevented fibrosis progression and lung cancer growth in idiopathic pulmonary fibrosis
A 76‐year‐old man with a past history of acute exacerbation (AE) and idiopathic pulmonary fibrosis (IPF) was treated with nintedanib because of decline in his forced vital capacity over time. A new small nodular lesion was visible on a computed tomography scan of the chest before initiation of ninte...
Salvato in:
| Pubblicato in: | Respirol Case Rep |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6138540/ https://ncbi.nlm.nih.gov/pubmed/30237884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.363 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|